Work

Engineered safe and immune-tolerant ‘designer’ rpe cells towards the treatment of age-related macular degeneration

Year: 2021

Type: article

Source: Cytotherapy

DOI: 10.1016/s1465324921002759

Authors: S. Hacibekiroglu, E. Jong, J. Tang, T. Oussenko, M. Ho, M. Shoichet, V. Wallace, P. Kertes, P. Yan, A. Nagy

Institutions: Lunenfeld-Tanenbaum Research Institute, University of Toronto, Donnelly Centre for Cellular and Biomolecular Research, Krembil Research Institute, Sunnybrook Health Science Centre, Kensington Health, Australian Regenerative Medicine Institute

Language: English

Topic: Retinal Development and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3160511195

FWCI:

Cites:

Cited by:

Related to: 10